Wegovy (Semaglutide) Weight Loss Injection USA
Price range: $150.00 through $570.00
Buy Wegovy (Semaglutide) Injections Online
Wegovy® is a GLP-1 receptor agonist, which means it works by mimicking the effects of a natural hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is released after eating and helps to control appetite, regulate blood sugar levels, and promote significant weight loss. Wegovy® is also approved to lower the risk of major cardiovascular events such as death, heart attack, or stoke, in adults with known heart disease and with either obesity or overweight.
Additional needles & sharps bins can be added to your basket during your assessment.
When to Use Wegovy (Semaglutide)?
Wegovy is a prescription that supports weight loss. As a GLP-1 receptor, it’s suitable for adults and some adolescents struggling to lose weight through exercise and diet alone.
If any of the following apply, Wegovy can be a beneficial treatment:
- Your BMI is Over 30: People with a BMI of 30 or over can use Wegovy. If you have a BMI of 27 and a weight-related comorbidity, you may also be eligible for the medication.
- Ethnic Groups: In some cases, individuals in ethnic groups including Africa, African-Caribbean, South Asian, Asian, and Middle Eastern may be able to use Wegovy with a lower BMI due to the higher risk of obesity-related illnesses.
Wegovy (Semaglutide) Age Restrictions
In most cases, Wegovy is suitable for adults between 18 and 75, as long as they meet the other eligibility criteria. However, adolescents with a high BMI who have tried other weight loss treatments may be eligible for Wegovy weight loss injection treatments if a medical professional feels it’s beneficial.
How to Use Wegovy (Semaglutide)?
Wegovy is a once-weekly injection, making it a popular alternative to many other weight-loss drugs. If you’re using it for the first time, it’s essential to check the flow by turning the dosage indicator until it shows the flow check symbol, then holding it away from you while you press the button.
If no drops appear, you may need to use a new pen or change the needle if possible. Most people choose the thigh, abdomen, or upper arm as an injection site – alternating between each.
Wegovy (Semaglutide) Dosage
Wegovy is available in a pre-filled pen containing 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg or 7.2mg (3x 2.4mg pens) of semaglutide.
Users should follow the dose escalation schedule under the supervision of medical professionals. The dosage is gradually increased over the first 16 weeks of treatment. The starting dose is 0.25 mg once weekly and increases to 7.2 mg once weekly.
Our specialists at Pharmacy Online can offer advice and discuss whether you can increase the dosage or should wait.
When to Avoid Using Wegovy (Semaglutide)?
Wegovy is not right for everyone, and it is important to talk to your doctor about the risks and benefits before starting treatment.
Do not take Wegovy if you have any of the following conditions:
- A history of pancreatitis
- Thyroid problems
- Certain types of cancer
- Pregnancy or breastfeeding
- Allergic to semaglutide or any of the inactive ingredients in Wegovy
Precautions
You should also talk to your doctor if you have any of the following conditions before starting Wegovy:
- Kidney or liver problems
- Eating disorders
- Mental health problems
- A history of low blood sugar
If Wegovy isn’t suitable for you, our current range of weight loss programmes can be found here, effective for 85% of prescribed patients.
Wegovy (Semaglutide) Ingredients
The active ingredient in Wegovy is semaglutide, a synthetic version of a naturally occurring hormone that helps regulate blood sugar levels.
The inactive ingredients are:
- Disodium phosphate dihydrate
- Sodium chloride
- Water for injection
- Hydrochloric acid or sodium hydroxide (to adjust pH)
The inactive ingredients are used to make the medication safe and effective.
FAQ About Wegovy (Semaglutide)
-
What is Wegovy?
Wegovy (semaglutide) medication is a once-weekly injection used to aid weight loss in adults with obesity, who are overweight (excess weight), or who have weight-related medical problems, to help them lose weight and keep the weight off.
It is specifically used for chronic weight management in adults with an initial body mass index (BMI) of:
- 30 kg/m2 or greater (obesity) or,
- 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition, such as hypertension (high blood pressure), type 2 diabetes or dyslipidemia.
Wegovy works by helping to regulate food intake and appetite. It is one of the most effective weight management products that has been shown to help users shed a percentage of their body weight, with the maintenance dose helping users maintain a healthy weight.
Wegovy should be used with a reduced calorie diet and increased physical activity.
Wegovy (semaglutide) should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
-
What is a glucagon-like peptide-1 (GLP-1) receptor agonist?
Wegovy is a synthetic version of the a naturally occurring hormone, glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of GLP-1 which is produced naturally by the gut, and to a lesser extent the pancreas and nervous system.
GLP-1 targets areas of the brain that help to regulate appetite, especially after eating. It also slows how quickly the stomach empties, which makes you feel fuller for longer. In addition to this, GLP-1 enhances the production of insulin.
-
What are the ingredients in Wegovy?
The active ingredient in Wegovy is semaglutide, a synthetic version of a naturally occurring hormone that helps regulate blood sugar levels.
The inactive ingredients are:
- Disodium phosphate dihydrate
- Sodium chloride
- Water for injection
- Hydrochloric acid or sodium hydroxide (to adjust pH)
The inactive ingredients are used to make the medication safe and effective.
-
What is the usual dosage for Wegovy?
Wegovy is available in a pre-filled pen containing either 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg or 7.2 mg of semaglutide.
Users should follow the dose escalation schedule under the supervision of medical professionals. The dosage is gradually increased over the first 16 weeks of treatment. The starting dose is 0.25 mg once weekly and increases to 7.2 mg once weekly.
| Strength | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, 2 Month Starter Pack – 0.25mg + 0.5mg, 3 Month Starter Pack – 0.25mg + 0.5mg + 1mg, 1mg Pen + 1.7mg Pen + 2.4mg Pen, 7.2mg (2.4mg x 3) |
|---|
Reviews